Object.The extent of tumor resection that should be undertaken in patients with glioblastoma multiforme (GBM) remains controversial. The purpose of this study was to identify significant independent predictors of survival in these patients and to determine whether the extent of resection was associated with increased survival time.
Methods.The authors retrospectively analyzed 416 consecutive patients with histologically proven GBM who underwent tumor resection at the authors' institution between June 1993 and June 1999. Volumetric data and other tumor characteristics identified on magnetic resonance (MR) imaging were collected prospectively.
Conclusions.Five independent predictors of survival were identified: age, Karnofsky Performance Scale (KPS) score, extent of resection, and the degree of necrosis and enhancement on preoperative MR imaging studies. A significant survival advantage was associated with resection of 98% or more of the tumor volume (median survival 13 months, 95% confidence interval [CI] 11.4–14.6 months), compared with 8.8 months (95% CI 7.4–10.2 months; p < 0.0001) for resections of less than 98%. Using an outcome scale ranging from 0 to 5 based on age, KPS score, and tumor necrosis on MR imaging, we observed significantly longer survival in patients with lower scores (1–3) who underwent aggressive resections, and a trend toward slightly longer survival was found in patients with higher scores (4–5). Gross-total tumor resection is associated with longer survival in patients with GBM, especially when other predictive variables are favorable.
Address reprint requests to:Raymond Sawaya, M.D., Department of Neurosurgery, Box 442, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030.
AlbertFK,,弗斯特M,&SartorK,et al:Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.开云体育app官方网站下载入口34:45–61,1994Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.Neurosurgery 34:45–61, 1994
Albert
FK
,
弗斯特
M
,
Sartor
K
,
et al
:
Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.开云体育app官方网站下载入口
34
:
45
–
61
,
1994
Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.
Neurosurgery 34:45–61, 1994)| false
AmmiratiM,,GalicichJH,&ArbitE,et al:Reoperation in the treatment of recurrent intracranial malignant gliomas.开云体育app官方网站下载入口21:607–614,1987Ammirati M, Galicich JH, Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas.Neurosurgery 21:607–614, 1987
Ammirati
M
,
Galicich
JH
,
Arbit
E
,
et al
:
Reoperation in the treatment of recurrent intracranial malignant gliomas.开云体育app官方网站下载入口
21
:
607
–
614
,
1987
Ammirati M, Galicich JH, Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas.
Neurosurgery 21:607–614, 1987
10.1227/00006123-198711000-00001)| false
AmmiratiM,,VickN,&LiaoY,et al:Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.开云体育app官方网站下载入口21:201–206,1987Ammirati M, Vick N, Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.Neurosurgery 21:201–206, 1987
Ammirati
M
,
Vick
N
,
Liao
Y
,
et al
:
Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.开云体育app官方网站下载入口
21
:
201
–
206
,
1987
Ammirati M, Vick N, Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.
Neurosurgery 21:201–206, 1987
10.1227/00006123-198708000-00012)| false
AndreouJ,,GeorgeAE,&WiseA,et al:CT prognostic criteria of survival after malignant glioma surgery.AJNR4:488–490,1983Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery.AJNR 4:488–490, 1983
Andreou
J
,
George
AE
,
Wise
A
,
et al
:
CT prognostic criteria of survival after malignant glioma surgery.AJNR
4
:
488
–
490
,
1983
Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery.
AJNR 4:488–490, 1983)| false
AvellanosaAM,,WestCR,&TsukadaY,et al:Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.Cancer44:839–846,1979Avellanosa AM, West CR, Tsukada Y, et al: Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.Cancer 44:839–846, 1979
Avellanosa
AM
,
West
CR
,
Tsukada
Y
,
et al
:
Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.Cancer
44
:
839
–
846
,
1979
Avellanosa AM, West CR, Tsukada Y, et al: Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
Cancer 44:839–846, 1979
10.1002/1097-0142(197909)44:3<839::AID-CNCR2820440308>3.0.CO;2-1)| false
BurgerPC,&GreenSB:Patient age, histological features, and length of survival in patients with glioblastoma multiforme.Cancer59:1617–1625,1987Burger PC, Green SB: Patient age, histological features, and length of survival in patients with glioblastoma multiforme.Cancer 59:1617–1625, 1987
Burger
PC
,
Green
SB
:
Patient age, histological features, and length of survival in patients with glioblastoma multiforme.Cancer
59
:
1617
–
1625
,
1987
Burger PC, Green SB: Patient age, histological features, and length of survival in patients with glioblastoma multiforme.
Cancer 59:1617–1625, 1987
10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X)| false
CoxDR:Regression models and life tables.J R Stat Soc B34:187–220,1972Cox DR: Regression models and life tables.J R Stat Soc B 34:187–220, 1972
Cox
DR
:
Regression models and life tables.J R Stat Soc B
34
:
187
–
220
,
1972
Cox DR: Regression models and life tables.
J R Stat Soc B 34:187–220, 1972)| false
CurranWJJr,,ScottCB,&HortonJ,et al:Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.J Neurooncol12:219–227,1992Curran WJ Jr, Scott CB, Horton J, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.J Neurooncol 12:219–227, 1992
Curran
WJ
Jr
,
Scott
CB
,
Horton
J
,
et al
:
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.J Neurooncol
12
:
219
–
227
,
1992
Curran WJ Jr, Scott CB, Horton J, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
J Neurooncol 12:219–227, 1992
10.1007/BF00172709)| false
Daumas-DuportC,,ScheithauerB,&O'FallonJ,et al:Grading of astrocytomas. A simple and reproducible method.Cancer62:2152–2165,1988Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method.Cancer 62:2152–2165, 1988
Daumas-Duport
C
,
Scheithauer
B
,
O'Fallon
J
,
et al
:
Grading of astrocytomas. A simple and reproducible method.Cancer
62
:
2152
–
2165
,
1988
Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method.
Cancer 62:2152–2165, 1988
10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T)| false
EarnestFIV,,KellyPJ,&ScheithauerBW,et al:Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy.Radiology166:823–827,1988Earnest F IV, Kelly PJ, Scheithauer BW, et al: Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy.Radiology 166:823–827, 1988
Earnest
F
IV
,
Kelly
PJ
,
Scheithauer
BW
,
et al
:
Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy.Radiology
166
:
823
–
827
,
1988
Earnest F IV, Kelly PJ, Scheithauer BW, et al: Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy.
Radiology 166:823–827, 1988
10.1148/radiology.166.3.2829270)| false
FadulC,,WoodJ,&ThalerH,et al:Morbidity and mortality of craniotomy for excision of supratentorial gliomas.Neurology38:1374–1379,1988Fadul C, Wood J, Thaler H, et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas.Neurology 38:1374–1379, 1988
Fadul
C
,
Wood
J
,
Thaler
H
,
et al
:
Morbidity and mortality of craniotomy for excision of supratentorial gliomas.Neurology
38
:
1374
–
1379
,
1988
Fadul C, Wood J, Thaler H, et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas.
Neurology 38:1374–1379, 1988
10.1212/WNL.38.9.1374)| false
GehanEA,&WalkerMD:Prognostic factors for patients with brain tumors.Natl Cancer Inst Monogr46:189–195,1977Gehan EA, Walker MD: Prognostic factors for patients with brain tumors.Natl Cancer Inst Monogr 46:189–195, 1977
Gehan
EA
,
Walker
MD
:
Prognostic factors for patients with brain tumors.Natl Cancer Inst Monogr
46
:
189
–
195
,
1977
Gehan EA, Walker MD: Prognostic factors for patients with brain tumors.
Natl Cancer Inst Monogr 46:189–195, 1977)| false
GilbertH,,KaganAR,&CassidyF,et al:Glioblastoma multiforme is not a uniform disease.Cancer Clin Trials4:87–89,1981Gilbert H, Kagan AR, Cassidy F, et al: Glioblastoma multiforme is not a uniform disease.Cancer Clin Trials 4:87–89, 1981
Gilbert
H
,
Kagan
AR
,
Cassidy
F
,
et al
:
Glioblastoma multiforme is not a uniform disease.Cancer Clin Trials
4
:
87
–
89
,
1981
Gilbert H, Kagan AR, Cassidy F, et al: Glioblastoma multiforme is not a uniform disease.
Cancer Clin Trials 4:87–89, 1981)| false
HammoudMA,,SawayaR,&ShiW,et al:Prognostic significance of preoperative MRI scans in glioblastoma multiforme.J Neurooncol27:65–73,1996Hammoud MA, Sawaya R, Shi W, et al: Prognostic significance of preoperative MRI scans in glioblastoma multiforme.J Neurooncol 27:65–73, 1996
Hammoud
MA
,
Sawaya
R
,
Shi
W
,
et al
:
Prognostic significance of preoperative MRI scans in glioblastoma multiforme.J Neurooncol
27
:
65
–
73
,
1996
Hammoud MA, Sawaya R, Shi W, et al: Prognostic significance of preoperative MRI scans in glioblastoma multiforme.
J Neurooncol 27:65–73, 1996
10.1007/BF00146086)| false
HarshGRIV,,LevinVA,&GutinPH,et al:Reoperation for recurrent glioblastoma and anaplastic astrocytoma.开云体育app官方网站下载入口21:615–621,1987Harsh GR IV, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma.Neurosurgery 21:615–621, 1987
Harsh
GR
IV
,
Levin
VA
,
Gutin
PH
,
et al
:
Reoperation for recurrent glioblastoma and anaplastic astrocytoma.开云体育app官方网站下载入口
21
:
615
–
621
,
1987
Harsh GR IV, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma.
Neurosurgery 21:615–621, 1987
10.1227/00006123-198711000-00002)| false
HessKR:Extent of resection as a prognostic variable in the treatment of gliomas.J Neurooncol42:227–231,1999Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas.J Neurooncol 42:227–231, 1999
Hess
KR
:
Extent of resection as a prognostic variable in the treatment of gliomas.J Neurooncol
42
:
227
–
231
,
1999
Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas.
J Neurooncol 42:227–231, 1999
10.1023/A:1006118018770)| false
KaplanEL,&MeierP:Nonparametric estimation from incomplete observations.J Am Stat Assoc53:457–481,1958Kaplan EL, Meier P: Nonparametric estimation from incomplete observations.J Am Stat Assoc 53:457–481, 1958
Kaplan
EL
,
Meier
P
:
Nonparametric estimation from incomplete observations.J Am Stat Assoc
53
:
457
–
481
,
1958
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations.
J Am Stat Assoc 53:457–481, 1958
10.1080/01621459.1958.10501452)| false
KellyPJ:Stereotactic biopsy and resection of thalamic astrocytomas.开云体育app官方网站下载入口25:185–195,1989Kelly PJ: Stereotactic biopsy and resection of thalamic astrocytomas.Neurosurgery 25:185–195, 1989
Kelly
PJ
,
Daumas-Duport
C
,
Kispert
DB
,
et al
:
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.J Neurosurg
66
:
865
–
874
,
1987
Kelly PJ, Daumas-Duport C, Kispert DB, et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.
J Neurosurg 66:865–874, 1987
10.3171/jns.1987.66.6.0865)| false
KiwitJC,,FloethFW,&BockWJ:Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery.Zentralbl Neurochir57:76–88,1996Kiwit JC, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery.Zentralbl Neurochir 57:76–88, 1996
Kiwit
JC
,
Floeth
FW
,
Bock
WJ
:
Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery.Zentralbl Neurochir
57
:
76
–
88
,
1996
Kiwit JC, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery.
Zentralbl Neurochir 57:76–88, 1996)| false
KleihuesP,,BurgerPC,&ScheithauerBW,et al:Histological Typing of Tumours of the Central Nervous System,ed 2.New York:Springer-Verlag,1993Kleihues P, Burger PC, Scheithauer BW, et al:Histological Typing of Tumours of the Central Nervous System, ed 2.New York: Springer-Verlag, 1993
Kleihues
P
,
Burger
PC
,
Scheithauer
BW
,
et al
:Histological Typing of Tumours of the Central Nervous System
,
ed 2
.
New York
:
Springer-Verlag
,
1993
Kleihues P, Burger PC, Scheithauer BW, et al:
Histological Typing of Tumours of the Central Nervous System, ed 2.New York: Springer-Verlag, 1993)| false
KrethFW,,WarnkePC,&ScheremetR,et al:Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.J Neurosurg78:762–766,1993Kreth弗兰克-威廉姆斯,Warnke PC, Scheremet R, et al:手术resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.J Neurosurg 78:762–766, 1993
Kreth
FW
,
Warnke
PC
,
Scheremet
R
,
et al
:
Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.J Neurosurg
78
:
762
–
766
,
1993
Kreth弗兰克-威廉姆斯,Warnke PC, Scheremet R, et al:手术resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.
J Neurosurg 78:762–766, 1993
10.3171/jns.1993.78.5.0762)| false
LaiDM,,LinSM,&TuYK,et al:Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.J Formos Med Assoc92:220–226,1993Lai DM, Lin SM, Tu YK, et al: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.J Formos Med Assoc 92:220–226, 1993
Lai
DM
,
Lin
SM
,
Tu
YK
,
et al
:
Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.J Formos Med Assoc
92
:
220
–
226
,
1993
Lai DM, Lin SM, Tu YK, et al: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.
J Formos Med Assoc 92:220–226, 1993)| false
NazzaroJM,&NeuweltEA:The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults.J Neurosurg73:331–344,1990Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults.J Neurosurg 73:331–344, 1990
Nazzaro
JM
,
Neuwelt
EA
:
The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults.J Neurosurg
73
:
331
–
344
,
1990
Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults.
J Neurosurg 73:331–344, 1990
10.3171/jns.1990.73.3.0331)| false
NewellJ,,RansohoffJ,&KaplanB:Glioblastoma in the older patient: how long a course of radiotherapy is necessary?J Neurooncol6:325–327,1988Newell J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary?J Neurooncol 6:325–327, 1988
Newell
J
,
Ransohoff
J
,
Kaplan
B
:
Glioblastoma in the older patient: how long a course of radiotherapy is necessary?J Neurooncol
6
:
325
–
327
,
1988
Newell J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary?
J Neurooncol 6:325–327, 1988)| false
NittaT,&SatoK:Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas.Cancer75:2727–2731,1995Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas.Cancer 75:2727–2731, 1995
Nitta
T
,
Sato
K
:
Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas.Cancer
75
:
2727
–
2731
,
1995
Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas.
Cancer 75:2727–2731, 1995
10.1002/1097-0142(19950601)75:11<2727::AID-CNCR2820751115>3.0.CO;2-H)| false
PradosMD,,GutinPH,&PhillipsTL,et al:Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989.IntJ Radiat Oncol Biol Phys23:3–8,1992Prados MD, Gutin PH, Phillips TL, et al: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989.IntJ Radiat Oncol Biol Phys 23:3–8, 1992
Quigley先生,&MaroonJC:The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas.开云体育app官方网站下载入口29:385–389,1991Quigley MR, Maroon JC: The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas.Neurosurgery 29:385–389, 1991
Quigley
先生
,
Maroon
JC
:
The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas.开云体育app官方网站下载入口
29
:
385
–
389
,
1991
Quigley MR, Maroon JC: The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas.
Neurosurgery 29:385–389, 1991
10.1227/00006123-199109000-00008)| false
SalcmanM:Resection and reoperation in neuro-oncology. Rationale and approach.Neurol Clin3:831–842,1985Salcman M:复位ction and reoperation in neuro-oncology. Rationale and approach.Neurol Clin 3:831–842, 1985
Salcman
M
:
Resection and reoperation in neuro-oncology. Rationale and approach.Neurol Clin
3
:
831
–
842
,
1985
Salcman M:复位ction and reoperation in neuro-oncology. Rationale and approach.
Neurol Clin 3:831–842, 1985
10.1016/S0733-8619(18)31012-0)| false
SawayaR:Extent of resection in malignant gliomas: a critical summary.J Neurooncol42:303–305,1999Sawaya R: Extent of resection in malignant gliomas: a critical summary.J Neurooncol 42:303–305, 1999
SawayaR,,HammoudM,&SchoppaD,et al:Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.开云体育app官方网站下载入口42:1044–1056,1998Sawaya R, Hammoud M, Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.Neurosurgery 42:1044–1056, 1998
Sawaya
R
,
Hammoud
M
,
Schoppa
D
,
et al
:
Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.开云体育app官方网站下载入口
42
:
1044
–
1056
,
1998
Sawaya R, Hammoud M, Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.
Neurosurgery 42:1044–1056, 1998
10.1097/00006123-199805000-00054)| false
ScottGM,&GibberdFB:Epilepsy and other factors in the prognosis of gliomas.Acta Neurol Scand61:227–239,1980Scott GM, Gibberd FB: Epilepsy and other factors in the prognosis of gliomas.Acta Neurol Scand 61:227–239, 1980
Scott
GM
,
Gibberd
FB
:
Epilepsy and other factors in the prognosis of gliomas.Acta Neurol Scand
61
:
227
–
239
,
1980
Scott GM, Gibberd FB: Epilepsy and other factors in the prognosis of gliomas.
Acta Neurol Scand 61:227–239, 1980)| false
SegallHD,,DestianS,&NelsonMDJr,et al:CT and MR imaging in malignant gliomas, inApuzzoMLJ(ed):Malignant Cerebral Glioma.Park Ridge, IL:American Association of Neurological Surgeons,1990, pp63–77Segall HD, Destian S, Nelson MD Jr, et al: CT and MR imaging in malignant gliomas, in Apuzzo MLJ (ed):Malignant Cerebral Glioma.Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp 63–77
Segall
HD
,
Destian
S
,
Nelson
MD
Jr
,
et al
:
CT and MR imaging in malignant gliomas
, in
Apuzzo
MLJ
(ed):Malignant Cerebral Glioma.
Park Ridge, IL
:
American Association of Neurological Surgeons
,
1990
, pp
63
–
77
Segall HD, Destian S, Nelson MD Jr, et al: CT and MR imaging in malignant gliomas, in Apuzzo MLJ (ed):
Malignant Cerebral Glioma.Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp 63–77)| false
ShapiroWR,,GreenSB,&BurgerPC,et al:Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001.J Neurosurg71:1–9,1989Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001.J Neurosurg 71:1–9, 1989
Shapiro
WR
,
Green
SB
,
Burger
PC
,
et al
:
Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001.J Neurosurg
71
:
1
–
9
,
1989
Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001.
J Neurosurg 71:1–9, 1989
10.3171/jns.1989.71.1.0001)| false
WalkerMD,,GreenSB,&ByarDP,et al:Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery.N Engl J Med303:1323–1329,1980Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery.N Engl J Med 303:1323–1329, 1980
Walker
MD
,
Green
SB
,
Byar
DP
,
et al
:
Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery.N Engl J Med
303
:
1323
–
1329
,
1980
Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery.
N Engl J Med 303:1323–1329, 1980
10.1056 / NEJM198012043032303)| false
WoodJR,,GreenSB,&ShapiroWR:The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.J Clin Oncol6:338–343,1988Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.J Clin Oncol 6:338–343, 1988
Wood
JR
,
Green
SB
,
Shapiro
WR
:
The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.J Clin Oncol
6
:
338
–
343
,
1988
Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.
J Clin Oncol 6:338–343, 1988
10.1200/JCO.1988.6.2.338)| false
